Literature DB >> 2579391

Bioeffective monoclonal antibody against the decapeptide gonadotropin-releasing hormone: reacting determinant and action on ovulation and estrus suppression.

G P Talwar, S K Gupta, V Singh, D Sahal, K S Iyer, O Singh.   

Abstract

A monoclonal antibody generated against the decapeptide gonadotropin-releasing hormone (GnRH) was effective in intercepting the bioactivity of the hormone; it blocked ovulation in rats. The antibody reacted optimally with the native hormone. Substitution of amide at the COOH terminus by a carboxyl group decreased immunoreactivity by a factor of 200. The antibody recognized the amino acid sequences 4-6, 7-10, and 4-10 to a variable degree, which suggests that the epitope has a conformation involving the entire molecule, with the NH2- and COOH-terminal regions probably in proximity. The antibody was also competent to suppress the progression of estrus in dogs, an indication that GnRH may play an inductive role in the reproductive function of dogs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579391      PMCID: PMC397228          DOI: 10.1073/pnas.82.4.1228

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  Study of the secondary structure of the luteinizing hormone releasing factor using intramolecular charge transfer complexes.

Authors:  B Donzel; J Rivier; M Goodman
Journal:  Biochemistry       Date:  1977-06-14       Impact factor: 3.162

2.  Conformational energy analysis of the molecule, luteinizing hormone-releasing hormone. I. Native decapeptide.

Authors:  F A Momany
Journal:  J Am Chem Soc       Date:  1976-05-12       Impact factor: 15.419

3.  Luteinizing hormone-releasing hormone: sequential versus conformational specificity of antiluteinizing hormone-releasing hormone sera.

Authors:  K C Copeland; M L Aubert; J Rivier; P C Sizonenko
Journal:  Endocrinology       Date:  1979-05       Impact factor: 4.736

4.  Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin.

Authors:  J P Louvet; G T Ross; S Birken; R E Canfield
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

5.  Studies on the total synthesis of an enzyme. V. The preparation of enzymatically active material.

Authors:  R Hirschmann; R F Nutt; D F Veber; R A Vitali; S L Varga; T A Jacob; F W Holly; R G Denkewalter
Journal:  J Am Chem Soc       Date:  1969-01-15       Impact factor: 15.419

6.  Immunogenicity of three C-terminal synthetic peptides of the beta subunit of human chorionic gonadotropin and properties of the antibodies raised against 45-amino acid C-terminal peptide.

Authors:  S Ramakrishnan; C Das; S K Dubey; M Salahuddin; G P Talwar
Journal:  J Reprod Immunol       Date:  1979-12       Impact factor: 4.054

Review 7.  Recent approaches to fertility control based on derivative of LH-RH.

Authors:  A V Schally; A Arimura; D H Coy
Journal:  Vitam Horm       Date:  1980       Impact factor: 3.421

8.  Neutralizing and non-neutralizing antibodies to bovine thyroid-stimulating hormone and its subunits.

Authors:  G N Beall; I J Chopra; D H Solomon; J G Pierce; J S Cornell
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

9.  A human chorionic gonadotropin-specific antiserum against synthetic peptide analogs to the carboxyl-terminal peptide of its beta-subunit.

Authors:  S Matsuura; M Ohashi; H C Chen; G D Hodgen
Journal:  Endocrinology       Date:  1979-02       Impact factor: 4.736

10.  The antigenic determinant of the LH-releasing hormone for three different antisera.

Authors:  A Arimura; H Sato; D H Coy; R B Worobec; A V Schally; N Yanaihara; T Hashimoto; C Yanaihara; N Sukura
Journal:  Acta Endocrinol (Copenh)       Date:  1975-02
  10 in total
  3 in total

Review 1.  Contraceptive vaccines.

Authors:  Rajesh K Naz
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Hormonotoxins: the role of positive charge of lysine residue on the immunological, biological and cytotoxic properties of ovine lutropin-S-S-gelonin conjugates.

Authors:  V Singh; R Curtiss
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

Review 3.  Milestones in contraceptive vaccines development and hurdles in their application.

Authors:  Satish Kumar Gupta; Abhinav Shrestha; Vidisha Minhas
Journal:  Hum Vaccin Immunother       Date:  2013-11-21       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.